I hope you’ll join me and a host of lung cancer experts on Saturday, October 3, 2015 at the GRACE ALK, ROS1 & EGFR Acquired Resistance in Lung Cancer Patient Forum. I’m on the faculty, speaking about lung cancer patient survivorship.

The forum is for ALK, ROS1 & EGFR lung cancer patients and their caregivers, and will be held at the Marriott Waterfront San Francisco. You can register and read the agenda (with a list of confirmed faculty) online.

At the forum, lung cancer patients can learn about research advances in lung cancers driven by ALK, ROS1, and EGFR. You’ll hear from leaders in targeted therapy research. In addition to presentations and question and answer sessions, attendees will have many opportunities to approach the faculty to speak with them directly. An evening reception after the event will enable additional face time and give attendees – many of whom know each other from online support groups – a chance to meet in real life.

Scheduled presentations include:

• Acquired Resistance & Why It Occurs
• Brain as a Sanctuary Site
• Repeat Biopsies and Serum-Based Testing
• Selecting Patients for Immunotherapy
• Quality of Life vs Progression Free Survival – What Are the Most Relevant Endpoints?
• Patient Assistance Programs
• Lung Cancer Survivorship

Additionally, breakouts for ALK/ROS1 patients and EGFR patients will cover issues specific to those patients:

• New Ideas and Treatment Options
• Individual Treatments for Individual Mutations
• Combinations to Prevent & Treat Acquired Resistance
• Drug Sequencing

Registration is $25 per person. GRACE has negotiated a group rate for rooms at the Marriott Waterfront San Francisco of $179 per night (request the “GRACE Patient Forum” room rate).

Hope to see you there!